Castle Biosciences CSTL Deferred Taxes
Deferred Taxes at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Castle Biosciences's deferred taxes?
- Castle Biosciences (CSTL) reported deferred taxes of -$10K in Q1 2026.
- How has Castle Biosciences's deferred taxes changed year-over-year?
- Castle Biosciences's deferred taxes increased by 98.7% year-over-year, from -$770K to -$10K.
- What is the long-term trend for Castle Biosciences's deferred taxes?
- Over 2 years (2021 to 2025), Castle Biosciences's deferred taxes has grown at a -14.8% compound annual growth rate (CAGR), from -$8.74M to -$6.34M.
- What does deferred taxes mean?
- Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.